Candriam S.C.A. - KEROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,625,024
-18.5%
741,061
+2.8%
0.17%
-20.1%
Q2 2023$28,972,231
-1.1%
721,061
-3.2%
0.21%
+3.0%
Q1 2023$29,282,543
-2.6%
745,057
+19.0%
0.20%0.0%
Q4 2022$30,054,982
+120.8%
625,914
+73.0%
0.20%
+111.5%
Q3 2022$13,611,000
+36.2%
361,7890.0%0.10%
+17.1%
Q2 2022$9,995,000
-56.3%
361,789
-14.0%
0.08%
-47.4%
Q1 2022$22,875,000
+62.3%
420,670
+74.6%
0.16%
+73.3%
Q4 2021$14,098,000
+47.9%
240,9460.0%0.09%
+38.5%
Q3 2021$9,531,000
+121.3%
240,946
+137.6%
0.06%
+124.1%
Q2 2021$4,307,000101,4090.03%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders